Drawing for SYMPTOMATE

USPTO serial 79272097

SYMPTOMATE

Reviewed by CopyMark Law Group

Reg. 6160793Status 739Renewal
Filing date
Status date
Registration date
Sep 29, 2020
Examiner
MCBRIDE, CAMERON L
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with SYMPTOMATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ryan Wertman

Ryan Wertman GrowthCounsel LLC2133 Arch Street Suite 200Philadelphia, PA 19103United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for the diagnosis of conditions of the human body; downloadable computer software programs for the diagnosis of conditions of the human body; downloadable data compression software; downloadable data communications software for the transmission of information supporting medical diagnosis to patients and end users; downloadable computer software to enable searching of data; downloadable computer software for document management; downloadable computer software for wireless content delivery; downloadable interactive computer software enabling exchange of information; downloadable computer software for use in system supporting medical decision-making; downloadable software for searching and retrieving information across a computer network; downloadable artificial intelligence software to enable and support the diagnosis of conditions of the human body; downloadable software based on artificial intelligence technology for use in providing IT solutions in the field of medicine and medical services; downloadable software for remote diagnostics; downloadable computer software capable to understand and analyze human questions and to formulate answers to these questions; downloadable computer software based on artificial intelligence for formulating conclusions based on available data; downloadable software based on artificial intelligence used for support decision making process for use in the field of medicine; downloadable computer software for use on handheld mobile digital electronic devices and other consumer electronicsACTIVE—
042Software as a service (SAAS) services featuring software for medical services relating to the diagnosis of conditions of the human body; Computer diagnostic services; development and creation of computer programs for data processing; rental of computer software; design, installation, updating and rental of computer software in the field of medical solutions; design, installation, updating and rental of application programming interface (API) for use with information technology equipment in the field of medical solutions; computer software design; computer software installation; updating of computer software; diagnosis of faults in computer software; design and development of diagnostic apparatus; design of diagnostics apparatus and equipment; design and development of medical diagnostic apparatus; design, installation, updating and implementation of computer software capable to understand and analyze human questions and formulate answers to these questionsACTIVE—
044Performing medical diagnosis of disease; medical services for the diagnosis of conditions of the human body; behavioral analysis for medical purposes; medical screening; health assessment survey services; consulting services relating to healthcare in the field of enabling end users to diagnose disease states and other conditions of the human body; medical information; medical consultations; arranging of medical treatment of disease states and other conditions of the human body; medical counseling; professional consultancy relating to health; professional consultancy relating to health care; providing medical information; provision of information relating to medicine; providing information relating to medical service; medical analysis services relating to the treatment of patients diagnosing of both terminal and non-terminal disease states and other common medical conditions of the human body; health advice and information services; consulting services relating to healthcare; advisory services relating to medical services; medical information services provided via the Internet; medical information; telemedicine services; medical analysis services diagnosis of both terminal and non-terminal disease states and other common medical conditions of the human body; providing health information; medical analysis services for cancer diagnosis and prognosis; medical treatment services for the diagnosis of both diagnosis of both terminal and non-terminal disease states and other common medical conditions of the human bodyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 12, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Feb 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 9, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 29, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 20, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 16, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 16, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 29, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 29, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 8, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 18, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 18, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 18, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 18, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2020RFNTREFUSAL PROCESSED BY IB—
Dec 21, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 21, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 27, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 26, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 19, 2019DOCKASSIGNED TO EXAMINER—
Nov 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance